Skip to main content

  • Short duration of dual antiplatelet therapy following complex percutaneous coronary intervention: A systematic review and meta-analysis

    • Posted: 04/17/2024
    • Author:

      Mohamed Magdi Eid, Mostafa Reda Mostafa, Ahmad Alabdouh, Mostafa Najim, Sarah Mohamed, Abdul Rahman Ziada, Andrew Takla, Mallory Balmer-Swain, Bipul Baibhav, Karim M. Al-Azizi and Andrew M. Goldsweig

    • 2024NewsCRM

    Abstract

    Introduction and aim

    The optimal composition and duration of antiplatelet therapy after complex percutaneous coronary intervention (PCI) remains unclear. We conducted a meta-analysis to compare 1–3 months of dual antiplatelet therapy (DAPT) followed by monotherapy vs. 12 months of DAPT.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details